Last --
Change Today 0.00 / 0.00%
Volume 0.0
4502 On Other Exchanges
Symbol
Exchange
4502 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Deborah Dunsire M.D.

Director, Member of Science & Technology Committee and Member of Corporate Governance & Compliance Committee, Allergan Inc.
AgeTotal Calculated CompensationThis person is connected to 154 board members in 3 different organizations across 7 different industries.

See Board Relationships
49$553,920

Background*

Dr. Deborah Dunsire, MD served as the President and Chief Executive Officer at Millennium Pharmaceuticals, Inc. since July 2005 until May 2013. Dr. Dunsire served as Corporate Officer at Millennium Pharmaceuticals, Inc. from June 24, 2011 to June 26, 2012. She joined Millennium in July 2005 with nearly 20 years of experience in the commercial, operational, clinical and scientific aspects of the pharmaceutical industry. She served as Corporate Officer at Takeda Pharmaceutical ...

Read Full Background

Corporate Headquarters*

1-1, Doshomachi 4-Chome
Osaka, -- 540-8645

Japan

Phone: 81 6 6204 2111
Fax: 81 6 6204 2880

Board Members Memberships*

Director
Director At Large
2006-Present
Director, Member of Science & Technology Committee and Member of Corporate Governance & Compliance Committee
2012-2013
Former Chief Executive Officer, President and Director
2012-N/A
Former Director, Chief Executive Officer of Millennium Pharmaceuticals Inc and President of Millennium Pharmaceuticals Inc

Education*

Unknown/Other Education
Wits Medical School
Doctorate
University of the Witwatersrand

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$91,248
Total Calculated Compensation$553,920
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4502:JP ¥4,800.00 JPY -165.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.3M
Paul M. Bisaro Chief Executive Officer, President and Director
Actavis, Inc.
$2.4M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.7M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Head of Human Genetic Therapies and Director
Shire plc
--
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAKEDA PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.